BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7295497)

  • 1. A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA).
    Browning RC; John VA; Till RJ; Theobald W
    Br J Clin Pharmacol; 1981 Oct; 12(4):600-2. PubMed ID: 7295497
    [No Abstract]   [Full Text] [Related]  

  • 2. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Nov; 14(5):321-48. PubMed ID: 201441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical evaluation of sustained release metoprolol durules in the treatment of angina pectoris.
    Comerford MB; Besterman EM
    Clin Cardiol; 1982 Feb; 5(2):131-5. PubMed ID: 7067184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
    Kendall MJ; Lambert L; Quarterman CP; John VA
    J Clin Hosp Pharm; 1981 Dec; 6(4):259-65. PubMed ID: 7338557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
    Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
    Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.
    Orö L
    Ann Clin Res; 1981; 13 Suppl 30():58-60. PubMed ID: 6794419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily treatment of stable angina pectoris.
    Howe A
    Practitioner; 1982 Sep; 226(1371):1621-4. PubMed ID: 6815627
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Duration of action of sustained-release metoprolol in effort angina pectoris].
    Cioglia G; Cherchi A; Mercuro G; Lai C; Lai O; Piras S
    Cardiologia; 1983 Mar; 28(3):253-65. PubMed ID: 6378220
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind comparison of long acting propranolol and sustained release metoprolol in the treatment of angina pectoris.
    Irving JB; Edwards RE
    Br J Clin Pract; 1987 Aug; 41(8):872-5. PubMed ID: 3329528
    [No Abstract]   [Full Text] [Related]  

  • 16. Atenolol and metoprolol once daily in hypertension.
    Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of metoprolol.
    Regårdh CG; Johnsson G
    Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs in current use: metoprolol.
    Greed R
    Aust Nurses J; 1979 Oct; 9(4):21-2. PubMed ID: 260674
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on drug therapy: III. Metoprolol.
    Robertson NJ; Elenbaas JK; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Mar; 35(3):65-7, 71-2. PubMed ID: 6245121
    [No Abstract]   [Full Text] [Related]  

  • 20. [Exercise tolerance in angina patients 3 and 24 hours after administration of a new delayed-action preparation of metoprolol].
    Giusti C; Verdecchia P; Pentimone F; Regoli F; Cordoni M; Bongini AM
    G Ital Cardiol; 1981; 11(11):1750-7. PubMed ID: 7343379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.